Exicure Inc (XCUR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. Chad A. Mirkin
Employees:
8045 LAMON AVE, SUITE 410, SKOKIE, IL 60077
847-673-1700

Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes AST-008 that is in a Phase 1b/2 clinical trials in patients with advanced solid tumors.

Data derived from most recent annual or quarterly report
Market Cap 10.134 Million Shares Outstanding88.121 Million Avg 30-day Volume 9.889 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.1
Price to Revenue0.0 Debt to Equity0.2697 EBITDA-23.237 Million
Price to Book Value2.5095 Operating Margin0.0 Enterprise Value88.859 Million
Current Ratio6.285 EPS Growth0.391 Quick Ratio5.977
1 Yr BETA 1.8798 52-week High/Low 1.98 / 0.1 Profit Margin0.0
Operating Cash Flow Growth-3081.7768 Altman Z-Score0.9436 Free Cash Flow to Firm -40.993 Million
View SEC Filings from XCUR instead.

View recent insider trading info

Funds Holding XCUR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding XCUR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GATES FRONTIER, LLC

GATES WILLIAM H III

  • 10% Owner
5,064,703 2021-12-21 1

GILJOHANN DAVID A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
38,666 2021-11-15 1

FELTNER DOUGLAS E. CHIEF MEDICAL OFFICER

  • Officer
15,000 2021-11-15 1

PAPADIMAS ELIAS D. CHIEF ACCOUNTING OFFICER

  • Officer
16,537 2021-08-27 2

SULAT JAMES R

  • Director
50,000 2021-06-02 1

WALBERT TIMOTHY P

  • Director
50,000 2021-06-02 1

SASSINE ANDY

  • Director
50,000 2021-06-02 1

CLELAND JEFFREY L

  • Director
50,000 2021-06-02 1

HAU BOSUN

  • Director
50,000 2021-06-02 1

MURALIDHAR BALI

  • Director
50,000 2021-06-02 1

GAROFALO ELIZABETH A.

  • Director
50,000 2021-06-02 1

SCHROFF MATTHIAS CHIEF OPERATING OFFICER

  • Officer
7,500 2021-05-14 0

BOCK BRIAN CHIEF FINANCIAL OFFICER

  • Officer
0 2021-05-13 0

VENKATESAN JAY

  • Director
672,288 2020-07-06 0

MIRKIN CHAD A.

  • Director
  • 10% Owner
11,381,214 2020-06-12 0

AURASENSE LLC

  • 10% Owner
11,257,629 2020-06-12 0

WALT DAVID R

  • Director
0 2020-06-04 0

KIM HELEN SUSAN

  • Director
0 2020-06-04 0

SNYDER DAVID S CHIEF FINANCIAL OFFICER

  • Officer
248,448 2020-03-12 0

THAXTON COLBY SHAD

  • Director
0 2019-06-14 0

TOMPKINS MARK N.

  • FORMER DIRECTOR AND 10% OWNER
No longer subject to file 2017-09-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EXICURE INC XCUR 2022-05-17 22:15:04 UTC -27.5483 28.3683 450000
EXICURE INC XCUR 2022-05-17 21:45:04 UTC -27.7423 28.5623 450000
EXICURE INC XCUR 2022-05-17 21:15:03 UTC -27.7423 28.5623 450000
EXICURE INC XCUR 2022-05-17 20:45:03 UTC -28.7254 29.5454 450000
EXICURE INC XCUR 2022-05-17 20:15:05 UTC -28.7254 29.5454 450000
EXICURE INC XCUR 2022-05-17 19:45:04 UTC -28.7254 29.5454 450000
EXICURE INC XCUR 2022-05-17 19:15:03 UTC -28.7254 29.5454 450000
EXICURE INC XCUR 2022-05-17 18:45:03 UTC -27.9852 28.8052 500000
EXICURE INC XCUR 2022-05-17 18:15:03 UTC -27.9852 28.8052 550000
EXICURE INC XCUR 2022-05-17 17:45:03 UTC -27.9852 28.8052 550000
EXICURE INC XCUR 2022-05-17 17:15:03 UTC -27.9852 28.8052 550000
EXICURE INC XCUR 2022-05-17 16:45:04 UTC -27.9852 28.8052 600000
EXICURE INC XCUR 2022-05-17 16:15:03 UTC -27.9852 28.8052 600000
EXICURE INC XCUR 2022-05-17 15:45:03 UTC -27.9852 28.8052 500000
EXICURE INC XCUR 2022-05-17 15:15:03 UTC -27.9852 28.8052 500000
EXICURE INC XCUR 2022-05-17 14:45:03 UTC -39.9201 40.7401 500000
EXICURE INC XCUR 2022-05-17 14:15:03 UTC -39.9201 40.7401 500000
EXICURE INC XCUR 2022-05-17 13:45:03 UTC -39.9201 40.7401 500000
EXICURE INC XCUR 2022-05-17 13:15:03 UTC -39.9201 40.7401 500000
EXICURE INC XCUR 2022-05-17 12:45:03 UTC -39.9201 40.7401 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments